These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17086134)

  • 21. BCG policy and tuberculosis control in Hungary.
    Lugosi L
    Dev Biol Stand; 1986; 58 ( Pt A)():15-21. PubMed ID: 3596027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong.
    Leung CC; Tam CM; Chan SL; Chan-Yeung M; Chan CK; Chang KC
    Int J Tuberc Lung Dis; 2001 Aug; 5(8):717-23. PubMed ID: 11495262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Six years' experience with the discontinuation of BCG vaccination. 1. Risk of tuberculosis infection and disease.
    Trnka L; Danková D; Svandová E
    Tuber Lung Dis; 1993 Jun; 74(3):167-72. PubMed ID: 8369510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Six years' experience with the discontinuation of BCG vaccination. 2. Cost and benefit of mass BCG vaccination.
    Trnka L; Danková D; Svandová E
    Tuber Lung Dis; 1993 Aug; 74(4):288-92. PubMed ID: 8219182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-benefit analysis of BCG-vaccination in Austria.
    Ambrosch F; Klima H; Wiedermann G
    Dev Biol Stand; 1979; 43():121-6. PubMed ID: 118066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial.
    Rodrigues LC; Pereira SM; Cunha SS; Genser B; Ichihara MY; de Brito SC; Hijjar MA; Dourado I; Cruz AA; Sant'Anna C; Bierrenbach AL; Barreto ML
    Lancet; 2005 Oct; 366(9493):1290-5. PubMed ID: 16214599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
    Pereira SM; Barreto ML; Pilger D; Cruz AA; Sant'Anna C; Hijjar MA; Ichihara MY; Santos AC; Genser B; Rodrigues LC
    Lancet Infect Dis; 2012 Apr; 12(4):300-6. PubMed ID: 22071248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating the effect of the 2005 change in BCG policy in England: a retrospective cohort study, 2000 to 2015.
    Abbott S; Christensen H; Welton NJ; Brooks-Pollock E
    Euro Surveill; 2019 Dec; 24(49):. PubMed ID: 31822330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Administration of the BCG vaccination using the multipuncture method in schoolchildren: a comparison with the intradermal method.
    Al Jarad N; Empey DW; Duckworth G
    Thorax; 1999 Sep; 54(9):762-4. PubMed ID: 10456967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intradermal BCG vaccination complications--analysis of 51 cases.
    de Souza GR; Sant'Anna CC; Lapa e Silva JR; Mano DB; Bethlem NM
    Tubercle; 1983 Mar; 64(1):23-7. PubMed ID: 6845431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bacillus Calmette-Guérin (BCG) vaccine coverage in newborns and infants at risk before and after a change in BCG policy].
    Parache C; Carcopino X; Gossot S; Retornaz K; Uters M; Mancini J; Garnier JM; Minodier P
    Arch Pediatr; 2010 Apr; 17(4):359-65. PubMed ID: 20219333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First experience with BCG discontinuation in Europe. Experience in Sweden 15 years after stopping general BCG vaccination at birth.
    Romanus V
    Bull Int Union Tuberc Lung Dis; 1990; 65(2-3):32-5. PubMed ID: 2257352
    [No Abstract]   [Full Text] [Related]  

  • 33. [Estimation of the epidemiological impact of various BCG vaccination scenarios in France].
    Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2005 Nov; 53(5):501-8. PubMed ID: 16434924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First experience with BCG discontinuation in Europe. Project on discontinuation of BCG vaccination in newborns in Czechoslovakia.
    Trnka L; Dankova D; Machova A; Svandova E; Hejdova E
    Bull Int Union Tuberc Lung Dis; 1990; 65(2-3):36-7. PubMed ID: 2257353
    [No Abstract]   [Full Text] [Related]  

  • 35. Research on BCG vaccination.
    ten Dam HG
    Adv Tuberc Res; 1984; 21():79-106. PubMed ID: 6433675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCG in Finland: changing from a universal to a selected programme.
    Salo EP
    Euro Surveill; 2006; 11(3):18-20. PubMed ID: 16567879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vaccination coverage and socioeconomic determinants of BCG vaccination in children before 3 months: Results of the Elfe cohort study, 2011].
    Guthmann JP; Ragot M; Ben Boutieb M; Bois C; Dufourg MN; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2016 Sep; 64(4):271-80. PubMed ID: 27553256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers to implementation of the new targeted BCG vaccination in France: a cross sectional study.
    Rossignol L; Guthmann JP; Kernéis S; Aubin-Auger I; Lasserre A; Chauvin P; Pelat C; Hanslik T; Lévy-Bruhl D; Blanchon T
    Vaccine; 2011 Jul; 29(32):5232-7. PubMed ID: 21609744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vaccine prophylaxis of tuberculosis: implication and problems].
    Aksenova VA; Levi DT; Fonina EV; Vundtsettel' NN
    Probl Tuberk Bolezn Legk; 2009; (1):10-6. PubMed ID: 19253677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacillus Calmette-Guérin (BCG) vaccination patterns in the province of Québec, Canada, 1956-1974.
    Rousseau MC; Conus F; Kâ K; El-Zein M; Parent MÉ; Menzies D
    Vaccine; 2017 Aug; 35(36):4777-4784. PubMed ID: 28705514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.